Elsalys Biotech
Jacques Mizrahi is a highly experienced professional currently working as a Venture Partner at Bioqube Ventures since May 2020. Prior to that, Jacques held leadership positions at Hoffmann-La Roche, starting in January 2010, where Jacques served as an Executive Leader in Cardiovascular & Metabolic Diseases. Their earlier roles at Roche included being the Head of Clinical Research and Exploratory Development for Metabolic and Vascular, as well as the Global Therapy Area Head for Metabolic and Vascular. Jacques holds an MSc and Ph.D. in Physiology and Pharmacology from Hop Pitie Salpetriere Paris and Uni Sherbrooke Quebec Canada.
This person is not in any offices
Elsalys Biotech
ElsaLys Biotech is a specialty pharmaceutical company, part of the Mediolanum Farmaceutici Spa group, focused on innovative medicines to address haemato-oncology related life-threatening and rare diseases.